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Abstract
Introduction: The occurrence of cytomegalovirus colitis is well known in immunosuppressed
patients, such as neoplastic patients following chemotherapy, although its exact etiology remains
unclear.
Case presentation: We present a case of cytomegalovirus colitis occurring in a 77-year-old man
with vomiting and diarrhea 2 weeks after initial systemic chemotherapy consisting of 5-fluorouracil,
leucovorin and irinotecan for a recurrent colorectal cancer. Initial colonoscopy revealed multiple
punched-out ulcers in the transverse colon and the diagnosis of cytomegalovirus was based on
positive cytomegalovirus antigen detected by indirect enzyme antibody method, although
immunohistological examination of tissues biopsied at colonoscopy was negative. The symptoms
ceased under ganciclovir and octreotide treatment, and the patient recovered gradually.
Conclusion: The most probable cause of the cytomegalovirus colitis in this case was impaired
immunity following chemotherapy. Cytomegalovirus infection should be included in the differential
diagnosis of gastrointestinal disease in colorectal cancer patients after chemotherapy and, when
suspected, the clinician should pursue appropriate diagnostic interventions including colonoscopy.
Introduction
Recently, a number of new treatment options have
become available for colorectal cancer (CRC) patients. In
particular, CPT-11 (irinotecan), a specific inhibitor of
topoisomerase I, has been proven to have efficacy in the
treatment of CRC. Most recent studies have demonstrated
a significant improvement in the addition of irinotecan to
5-fluorouracil (5-FU)-leucovorin (LV) combination ther-
apy (FOLFIRI) for patients with 5-FU-refractory advanced
CRC. In contrast, immunosuppression induced by chem-
otherapy is less well characterized, with opportunistic
infections appearing mainly after high-dose treatment or
with certain new drugs directly affecting lymphocyte
homeostasis. The occurrence of cytomegalovirus (CMV)
colitis is well known in immunosuppressed patients, such
as neoplastic patients after chemotherapy, although its
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exact etiology remains unclear. We describe the case of a
77-year-old man presenting with an unusual viral compli-
cation with CMV colitis diagnosed 2 weeks after a first
course of standard chemotherapy for a recurrent CRC.
Case presentation
A 77-year-old man with known recurrence of colon can-
cer, which was not previously treated with any adjuvant
chemotherapies, was admitted for vomiting and diarrhea
2 weeks after standard FOLFIRI chemotherapy consisting
of 5-FU (350 mg/bolus/m2 plus 2300 mg/infuser pump/
m2), LV (200 mg/m2) and irinotecan (130 mg/m2). Labo-
ratory examination on admission showed a white blood
cell count of 15,300/mcl and C-reactive protein of 16.4
mg/dl, and he was also slightly anemic. Blood, urine and
stool cultures as well as Clostridium difficile toxin 33
assay for stool specimen results were negative.
Abdominal computed tomography imaging revealed a
massive dilatation of the entire colon (Figure 1). Subse-
quently, a colonoscopy was performed, which revealed
multiple punched-out ulcers in the transverse colon (Fig-
ure 2A and 2B) typical for CMV colitis. Following colon-
oscopy, CMV antigen was detected by indirect enzyme
antibody method, also known as antigenemia method,
but the biopsy specimens did not reveal CMV inclusion
body immunohistologically. Based on these findings, the
patient was diagnosed with CMV colitis and was started
on intravenous ganciclovir therapy (500 mg/day for 2
weeks) combined with subcutaneous octreotide (200
mcg/day for 10 days). The patient gradually improved,
and a second colonoscopy 4 weeks after admission dem-
onstrated partial healing of multiple ulcers in the trans-
verse colon (Figure 3).
Discussion
Although CMV colitis is not frequently encountered,
severe CMV colitis has been reported in neoplastic
patients after chemotherapy [1,2]. The diagnosis of CMV
colitis often poses a clinical challenge. Although endo-
scopic biopsies taken from the mucosa and ulcer bed are
a relatively rapid and reliable method for demonstrating
CMV colitis, their sensitivity is sometimes limited [3].
CMV antigen in the blood may also confirm the diagnosis
of CMV colitis [1] as in this case but may not always be
present. Furthermore, the clinical symptoms of CMV coli-
tis are indistinguishable from irinotecan-induced enteri-
Abdominal computed tomography shows massive large  bowel dilatation of the entire colon Figure 1
Abdominal computed tomography shows massive 
large bowel dilatation of the entire colon.
Initial colonoscopy reveals multiple punched-out ulcers of  the right transverse colon (A) and the left transverse colon  (B) with minimal granularity in the surrounding mucosa Figure 2
Initial colonoscopy reveals multiple punched-out 
ulcers of the right transverse colon (A) and the left 
transverse colon (B) with minimal granularity in the 
surrounding mucosa.
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tis, another infrequently seen but important cause of
severe colitis [4,5].
In our case, since the CMV antigen was positive, it is
unlikely that the patient's colitis was directly related to the
use of irinotecan, but the high-dose irinotecan may have
been the major predisposing factor for the activation of
CMV. Moreover, although it has been reported that iri-
notecan has the potential to induce neutropenia [5], our
case showed an elevation of the leukocyte count, presum-
ably caused by the colitis itself and the micro-abscesses.
The primary therapy for CMV colitis is the use of antiviral
drugs such as ganciclovir. In addition, previous reports
have shown that octreotide also has potential for use
against CMV colitis, although its mechanism of action
remains unclear [2,6]. Our case demonstrated a favorable
response to these treatments. Despite successful treat-
ment, elective surgery is warranted if intestinal stenosis
develops after the punched-out ulcer has healed [7].
Although the overall frequency of CMV infection in
patients with neoplasm after chemotherapy is uncertain,
CMV colitis should be ruled out with colonoscopy if the
patient is suspected of having atypical enteritis after chem-
otherapy, as demonstrated in our case.
As the clinical pathological features of CMV colitis and
inflammatory bowel disease often overlap, and because of
the possible co-existence of CMV colitis with idiopathic
colitis, the possibility of CMV infection should always be
considered, so that the most appropriate therapy can be
instituted for these patients.
Conclusion
This case demonstrates that CMV colitis appears to be an
extremely rare but potentially serious complication for
patients with CRC following chemotherapy. Therefore, in
individuals with CRC who do not respond to traditional
medical therapy, other diagnoses including CMV should
be considered, with early examinations of colonoscopy
with biopsy and CMV antigenemia.
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Follow-up colonoscopy demonstrates partial healing of the  ulcers in the transverse colon Figure 3
Follow-up colonoscopy demonstrates partial healing 
of the ulcers in the transverse colon.